Anti-GBM pulmonary-renal syndrome: when the laboratory makes the difference​Carmen Frías Ruizon May 15, 2026 at 10:00 am

Adv Lab Med. 2026 Jan 12;7(2):160-162. doi: 10.1515/almed-2025-0099. eCollection 2026 Jun.

ABSTRACT

OBJECTIVES: Pulmonary-renal syndrome (PRS) is a serious condition characterized by concurrent alveolar hemorrhage and rapidly progressive glomerulonephritis. One of the potential causes of PRS is the presence of anti-glomerular basement membrane (anti-GBM) antibodies, which may induce Goodpasture syndrome, a rare, albeit life-threatening, condition associated with a high mortality.

CASE PRESENTATION: We report the case of a 31 year-old male patient with Huntington’s disease who presented with dyspnea, a dry cough, and asthenia. Urgent laboratory tests demonstrated severe anemia, acute kidney failure, and additional laboratory abnormalities consistent with vasculitis. Chest CT scan revealed diffuse alveolar hemorrhage. The autoimmune panel was anti-GBM positive, thereby leading to diagnosis of Goodpasture syndrome.

CONCLUSIONS: Goodpasture syndrome is a form of pulmonary-renal syndrome that requires prompt diagnosis and intensive immunosuppressive therapy. Patients may follow a severe course and progress into end-stage renal disease. Early detection of anti-GBM antibodies is essential for diagnosis. The clinical laboratory plays a major role in supporting therapeutic decision-making and treatment response monitoring.

PMID:42136978 | PMC:PMC13169443 | DOI:10.1515/almed-2025-0099

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520